1. BLN4: Fifth Gen Warfare with Drs. Robert Malone, Jill Malone, Byram Bridle & Mark Trozzi -Part 4

    BLN4: Fifth Gen Warfare with Drs. Robert Malone, Jill Malone, Byram Bridle & Mark Trozzi -Part 4

    47
    0
    5.78K
    6
  2. Dr. Richard M Fleming Scientifically Explains How COVID-19 is a Bio-weapon

    Dr. Richard M Fleming Scientifically Explains How COVID-19 is a Bio-weapon

    78
    0
    18.7K
    16
  3. Jim Caviezel | Exposing America to Adrenochrome | ReAwaken America Tour Tulsa

    Jim Caviezel | Exposing America to Adrenochrome | ReAwaken America Tour Tulsa

    91
    1
    4.09K
    4
  4. Human Cloning 2022 Pt 1: Narrated by Donald Marshall (Forced Vaxxed - Why not forced Cloning?)

    Human Cloning 2022 Pt 1: Narrated by Donald Marshall (Forced Vaxxed - Why not forced Cloning?)

    52
    0
    7.52K
    8
  5. Paramedic Witnessed Woman Die IN LINE For Pfizer mRNA - Second One In Two Weeks – Ask Dr. Drew

    Paramedic Witnessed Woman Die IN LINE For Pfizer mRNA - Second One In Two Weeks – Ask Dr. Drew

    7
    0
    381
    1
  6. Bonus 10 - DISCOVER: Cutting-Edge Regenerative Medicine and Healing Protocols - Absolute Healing

    Bonus 10 - DISCOVER: Cutting-Edge Regenerative Medicine and Healing Protocols - Absolute Healing

    5
    0
    676
  7. The End of Germ Theory

    The End of Germ Theory

    5
    0
    557
  8. Dr. David E. Martin | Testimony - Corona Virus Patents and information

    Dr. David E. Martin | Testimony - Corona Virus Patents and information

    9
    0
    966
    1
  9. "mRNA technology is a good fit for gene editing. We want to make these editing proteins for just a short period of time to modify the genome. And producing the editing enzymes transiently helps to reduce the potential for off-target effects."

    "mRNA technology is a good fit for gene editing. We want to make these editing proteins for just a short period of time to modify the genome. And producing the editing enzymes transiently helps to reduce the potential for off-target effects."

    42
    1
    3.87K
    25